Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Marshall

Showing results (651-660 of 679) with videos related to

Pageof 68
Sort By:
Thorax|April 23, 2016
Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPFPaul F Mercer, Hannah V Woodcock, Jessica D Eley, et al.
The Lancet. Respiratory Medicine|November 19, 2017
An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort studyToby M Maher, Eunice Oballa, Juliet K Simpson, et al.
Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses|June 19, 2026
What does respiratory physiotherapy look like for patients requiring prolonged mechanical ventilation in Australia? A prospective multicentre audit of practiceCaitlin Ironside, Marc Nickels, I Anne Leditschke, et al.
The Journal of Cell Biology|March 16, 2011
Control of bone formation by the serpentine receptor Frizzled-9Joachim Albers, Jochen Schulze, F Timo Beil, et al.
Protein Science : a Publication of the Protein Society|November 25, 1998
Solution structures of stromelysin complexed to thiadiazole inhibitorsB J Stockman, D J Waldon, J A Gates, et al.
Journal of Medicinal Chemistry|September 15, 2018
Discovery of ( S)-3-(3-(3,5-Dimethyl-1 H-pyrazol-1-yl)phenyl)-4-(( R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid, a Nonpeptidic αPanayiotis A Procopiou, Niall A Anderson, John Barrett, et al.
The Annals of Thoracic Surgery|March 28, 2001
Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study GroupG R DeFoe, C S Ross, E M Olmstead, et al.
The European Respiratory Journal|February 16, 2019
A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosisPauline T Lukey, Stephen A Harrison, Shuying Yang, et al.
Nature Medicine|May 19, 2009
Impaired gastric acidification negatively affects calcium homeostasis and bone massThorsten Schinke, Arndt F Schilling, Anke Baranowsky, et al.
Nature Communications|September 12, 2020
Author Correction: The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesisHannah V Woodcock, Jessica D Eley, Delphine Guillotin, et al.
Pageof 68

Showing results (651-660 of 679) with videos related to

Sort By:
Pageof 68
Thorax|April 23, 2016
Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPFPaul F Mercer, Hannah V Woodcock, Jessica D Eley, et al.
The Lancet. Respiratory Medicine|November 19, 2017
An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort studyToby M Maher, Eunice Oballa, Juliet K Simpson, et al.
Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses|June 19, 2026
What does respiratory physiotherapy look like for patients requiring prolonged mechanical ventilation in Australia? A prospective multicentre audit of practiceCaitlin Ironside, Marc Nickels, I Anne Leditschke, et al.
The Journal of Cell Biology|March 16, 2011
Control of bone formation by the serpentine receptor Frizzled-9Joachim Albers, Jochen Schulze, F Timo Beil, et al.
Protein Science : a Publication of the Protein Society|November 25, 1998
Solution structures of stromelysin complexed to thiadiazole inhibitorsB J Stockman, D J Waldon, J A Gates, et al.
Journal of Medicinal Chemistry|September 15, 2018
Discovery of ( S)-3-(3-(3,5-Dimethyl-1 H-pyrazol-1-yl)phenyl)-4-(( R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid, a Nonpeptidic αPanayiotis A Procopiou, Niall A Anderson, John Barrett, et al.
The Annals of Thoracic Surgery|March 28, 2001
Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study GroupG R DeFoe, C S Ross, E M Olmstead, et al.
The European Respiratory Journal|February 16, 2019
A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosisPauline T Lukey, Stephen A Harrison, Shuying Yang, et al.
Nature Medicine|May 19, 2009
Impaired gastric acidification negatively affects calcium homeostasis and bone massThorsten Schinke, Arndt F Schilling, Anke Baranowsky, et al.
Nature Communications|September 12, 2020
Author Correction: The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesisHannah V Woodcock, Jessica D Eley, Delphine Guillotin, et al.
Pageof 68